Psychophysics in Glaucoma. A Modified Concept of the Disease. In: Greve EL, Leydhecker W, Raitta C, editors. Second European Glaucoma Symposium, Helsinki, May 1984. Dordrecht: Springer Netherlands; 1985. pp. 11-7. [DOI: 10.1007/978-94-009-5516-5_2]

Histamine H3 receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection

Glaucoma is a degenerative optic neuropathy in which the degeneration of optic nerve and blindness occur. The main cause is a malfunction of ciliary processes (protrusions of the ciliary bodies) resulting in increased intraocular pressure (IOP). Ocular hypertension (OHT) causes ischemic events leading to retinal ganglion cell (RGC) depletion and blindness. Histaminergic and nitrergic systems are involved in the regulation of IOP. Therefore, we developed novel hybrid compounds that target histamine H3 receptor (H3R) with nitric oxide (NO) releasing features (ST-1989 and ST-2130). After H3R binding was proven in vitro, we investigated their effects in two OHT models in New Zealand White rabbits. Compound ST-1989 showed the highest NO elevation, together with antioxidative and anti-inflammatory features partly superior to the co-administered H3R antagonist (ciproxifan) and NO donor (molsidomine). This hybrid compound demonstrated IOP reduction in both OHT models induced by intravitreal injection of hypertonic saline and carbomer into the anterior chamber of the eye, respectively. Ocular perfusion and photoreceptor neuroprotection were evaluated in a model of ischemia/reperfusion (I/R) of the ophthalmic artery induced by repeated sub-tenon injections of endothelin-1 (ET-1), twice a week for six weeks. Compound ST-1989 counteracts retinal degeneration reducing ophthalmic artery resistance index and increasing photoreceptor responses, thus rescuing RGCs. Our results indicate that compound ST-1989 is a promising molecule with long-lasting hypotensive effects and good effectiveness in reducing inflammation, oxidative stress, and RGCs apoptosis. In conclusion, these hybrid compounds could be a novel strategy to combat glaucomatous blindness and RGC depletion for ocular diseases involving retinal damage.

The discovery of the Flammer syndrome: a historical and personal perspective

This review describes the clinical and basic research that led to the description of Flammer syndrome. It is narrated from a personal perspective. This research was initiated by the observation of an increased long-term fluctuation of visual fields in a subgroup of glaucoma patients. As these patients had strikingly cold hands, peripheral blood flow was tested with a capillary microscopy, and vasospastic syndrome (VS) was diagnosed. Further studies on these patients revealed frequently weakened autoregulation of ocular blood flow and increased flow resistivity in retroocular vessels. Their retinal vessels were more rigid and irregular and responded less to flickering light. Holistic investigation demonstrated low blood pressure, silent myocardial ischaemia, altered beat-to-beat variation, altered gene expression in the lymphocytes, slightly increased plasma endothelin level and increased systemic oxidative stress. This combination of signs and symptoms was better described by the term primary vascular dysregulation (PVD) than by VS. Subsequent studies showed additional symptoms frequently related to PVD, such as low body mass index, cold extremities combined with slightly increased core temperature, prolonged sleep onset time, reduced feelings of thirst, increased sensitivity to smell and also for certain drugs and increased retinal venous pressure. To better characterise this entire syndrome, the term Flammer syndrome (FS) was introduced. Most subjects with FS were healthy. Nevertheless, FS seemed to increase the risk for certain eye diseases, particularly in younger patients. This included normal-tension glaucoma, anterior ischaemic optic neuropathy, retinal vein occlusions, Susac syndrome and central serous chorioretinopathy. Hereditary diseases, such as Leber’s optic neuropathy or retinitis pigmentosa, were also associated with FS, and FS symptoms and sings occurred more frequent in patients with multiple sclerosis or with acute hearing loss. Further research should lead to a more concise definition of FS, a precise diagnosis and tools for recognizing people at risk for associated diseases. This may ultimately lead to more efficient and more personalised treatment.

A novel strategy for the estimation of the general height of the visual field in patients with glaucoma

BACKGROUND

More accurate estimation of the general height of the visual field may improve our ability to detect and monitor progression of diseases affecting visual function such as glaucoma. General height (GH) can be affected by factors such as cataracts, pupillary miosis, refractive error, and learning and fatigue effects. The conventional GH index, consisting of subtracting the 85th largest value from the total-deviation map, has been shown to overestimate the height in patients with moderate and advanced glaucoma. We aimed at developing an improved estimator for general height based on ranking of total-deviation values that are within normal limits (GHr).

METHODS

Two datasets were used for the comparisons between GH and GHr estimates: one with 369 visual fields for 102 controls, and another with 500 visual fields for 124 patients. For controls, we compared the distributions of mean of total deviation (MD) and of mean of pattern deviation (MPD) derived from both the GH and the GHr estimates. For patients, we assessed agreement between both estimates and between pairs of consecutive visits. We also compared linear fits in progression analyses. All data were collected with 24-2 SITA Standard.

RESULTS

For control subjects and patients with MD above -5.5 dB, estimates with the GHr estimator were not significantly different than with the GH estimator. For patients with glaucoma with MD below -5.5 dB, as MD became more negative the GH estimates were increasingly greater than GHr estimates. For patients with glaucoma, test-retest variability was lower with the GHr estimator: between visits agreement was better for GHr estimates than for GH estimates (SD of 0.8 dB versus 1.5 dB; p < 0.0001). Linear-regression analysis fitted better estimates obtained with the GHr estimator. Root mean square error for GHr was 0.4 dB; lower than the 0.8 dB for GH (p < 0.0001).

CONCLUSIONS

The novel GHr estimator is very different from the conventional GH estimator, has more solid foundations, and better statistical properties. Nevertheless, it is not always better than the GH estimator, in particular if no focal loss is present. Pattern-deviation maps obtained with GHr reduce systematic underestimation of glaucomatous damage.

Comparison of retinal nerve fiber layer measurements between NTG and HTG using GDx-vCC

PURPOSE

To compare quantitative polarimetric measurements in eyes with NTG and HTG using GDx-VCC. Both groups were matched by age and glaucoma stage based on the Humphrey visual field test.

METHODS

We retrospectively reviewed the records of 146 patients who underwent Humphrey field analysis (HFA) and GDx-VCC. We compared outcomes of retinal nerve fiber layer (RNFL) parameters among the three groups by ANOVA and between each pair of groups using the Tukey-Kramer Post-Hoc test. We also evaluated the sensitivity and specificity of GDx-VCC in detecting glaucoma in each group.

RESULTS

The mean age and HFA mean deviation (MD) were 55.6 +/- 9.5 years and -0.8 +/- 1.5 dB in 47 control patients, 59.4 +/- 9.0 years and -5.77 +/- 4.38 dB in 49 NTG patients, and 59.4 +/- 11.7 years and -8.09 +/- 6.77 dB in 51 HTG patients, respectively. All thickness parameters were lower in HTG patients compared to NTG patients, but there were no significant differences in ratio parameters between age-matched early HTG and NTG patients. The sensitivity of GDx-VCC was significantly higher in both early and total HTG patients compared to the respective groups of NTG patients.

CONCLUSIONS

Compared to eyes with NTG, eyes with HTG showed reduced RNFL thickness and ratio parameters when patients were age and visual field matched. GDx-VCC appeared to be more sensitive in detecting RNFL damage in HTG patients.

The impact of ocular blood flow in glaucoma

Two principal theories for the pathogenesis of glaucomatous optic neuropathy (GON) have been described--a mechanical and a vascular theory. Both have been defended by various research groups over the past 150 years. According to the mechanical theory, increased intraocular pressure (IOP) causes stretching of the laminar beams and damage to retinal ganglion cell axons. The vascular theory of glaucoma considers GON as a consequence of insufficient blood supply due to either increased IOP or other risk factors reducing ocular blood flow (OBF). A number of conditions such as congenital glaucoma, angle-closure glaucoma or secondary glaucomas clearly show that increased IOP is sufficient to lead to GON. However, a number of observations such as the existence of normal-tension glaucoma cannot be satisfactorily explained by a pressure theory alone. Indeed, the vast majority of published studies dealing with blood flow report a reduced ocular perfusion in glaucoma patients compared with normal subjects. The fact that the reduction of OBF often precedes the damage and blood flow can also be reduced in other parts of the body of glaucoma patients, indicate that the hemodynamic alterations may at least partially be primary. The major cause of this reduction is not atherosclerosis, but rather a vascular dysregulation, leading to both low perfusion pressure and insufficient autoregulation. This in turn may lead to unstable ocular perfusion and thereby to ischemia and reperfusion damage. This review discusses the potential role of OBF in glaucoma and how a disturbance of OBF could increase the optic nerve's sensitivity to IOP.

Glaucomatous damage patterns by short-wavelength automated perimetry (SWAP) in glaucoma suspects

PURPOSE

To determine the glaucomatous visual field damage patterns by short-wavelength automated perimetry (SWAP) in glaucoma suspects, and to compare the frequency of diffuse visual field losses and localized defects.

METHODS

157 eyes of 157 ocular hypertensive subjects who met the selection criteria (intraocular pressure greater than 21 mm Hg and normal standard visual fields) were studied. SWAP was done with a modified Humphrey Field Analyzer. Total (TD) and Pattern Deviation (PD) probability maps were calculated for SWAP. The frequency of abnormlities in the TD and PD were determined, analyzing the visual field loss components.

RESULTS

The involvement of the test points was more frequent on the TD plots than on the PD plots for all levels of defects (p< 0.001). The glaucomatous defects also showed certain topographical distribution.

CONCLUSIONS

A diffuse sensitivity component of visual field loss was found at all SWAP defect depths in glaucoma suspects.

Primary argon laser trabeculoplasty vs pilocarpine. III. Long-term effects on visual fields

In a prospective randomized study on primary argon laser trabeculoplasty vs pilocarpine in 82 newly detected open-angle glaucoma patients, visual field changes were analysed for absolute changes over 2 years on automated threshold perimetry and manual Goldmann perimetry. Regression analysis was also performed using the threshold perimetry examinations taken every second month. Analyses based on automatic perimetry were corrected for eventual bias due to cataract and induced miosis. There was significantly less decay of visual field in the group treated with laser. This was even more pronounced for eyes with capsular glaucoma, especially in the early stage. For the smaller group with simple glaucoma no significant advantage of laser could be shown. Successful intraocular pressure reduction significantly improved the visual field outcome. Laser trabeculoplasty is therefore recommended as primary therapy in capsular glaucoma.

Lack of diffuse loss of differential light sensitivity in early glaucoma

We studied the differential light sensitivity in 83 patients who were prospectively followed with computerized threshold preimetry and optic disc pathography because of suspect glaucoma. Eyes with media opacities were excluded from the analysis. Fourteen eyes developed progressive optic disc cupping and/or localized visual field loss. In this glaucoma group light sensitivity in the 10 best points in the visual field did not deviate more from estimated age-corrected standard values than in the remaining groups of 115 eyes with increased intraocular pressure and 18 normotensive eyes. The results do not support the concept that diffuse loss of differential light sensitivity should be common in early glaucoma.

A comparison of the blue color mechanism in high- and low-tension glaucoma

Twenty-five eyes of 25 high-tension glaucoma patients and 25 eyes of 25 low-tension glaucoma patients matched for similar visual field defects had their spectral increment threshold measured. Patients with high-tension glaucoma showed significant losses in both chromatic and achromatic sensitivities when compared with low-tension glaucoma patients. The results support the hypothesis that there may be different mechanisms of damage in glaucoma.